Paper36978112
Host-mediated RNA editing in viruses.
Zhu T and 6 others. Biol Direct, 2023. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Host-mediated RNA editing in viruses. Papers, record 36978112. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978112
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Viruses | Major topic |
| Humans | |
| RNA Editing |
Source PubMed
References148
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19651874 | Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. | Nucleic Acids Res | 2009 | https://conductscience.org/library/papers/19651874 | PubMed |
| 2 | 17625792 | Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. | Hepatology | 2007 | https://conductscience.org/library/papers/17625792 | PubMed |
| 3 | 34346762 | Marburg and Ebola Virus mRNA 3' Untranslated Regions Contain Negative Regulators of Translation That Are Modulated by ADAR1 Editing. | J Virol | 2021 | https://conductscience.org/library/papers/34346762 | PubMed |
| 4 | 21763507 | Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif. | J Mol Biol | 2011 | https://conductscience.org/library/papers/21763507 | PubMed |
| 5 | 35922514 | RNA editing underlies genetic risk of common inflammatory diseases. | Nature | 2022 | https://conductscience.org/library/papers/35922514 | PubMed |
| 6 | 20192758 | Functions and regulation of RNA editing by ADAR deaminases. | Annu Rev Biochem | 2010 | https://conductscience.org/library/papers/20192758 | PubMed |
| 7 | 17672864 | Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression. | Cell Microbiol | 2008 | https://conductscience.org/library/papers/17672864 | PubMed |
| 8 | 17251560 | Dual effect of APOBEC3G on Hepatitis B virus. | J Gen Virol | 2007 | https://conductscience.org/library/papers/17251560 | PubMed |
| 9 | 29610985 | Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription. | Arch Virol | 2018 | https://conductscience.org/library/papers/29610985 | PubMed |
| 10 | 17855362 | APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17855362 | PubMed |
| 11 | 23519203 | Synthesis and antiviral activity of N-phenylbenzamide derivatives, a novel class of enterovirus 71 inhibitors. | Molecules | 2013 | https://conductscience.org/library/papers/23519203 | PubMed |
| 12 | 25086286 | Global epidemiology and genotype distribution of the hepatitis C virus infection. | J Hepatol | 2014 | https://conductscience.org/library/papers/25086286 | PubMed |
| 13 | 33801257 | The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense. | Viruses | 2021 | https://conductscience.org/library/papers/33801257 | PubMed |
| 14 | 26865163 | Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response. | J Cell Mol Med | 2016 | https://conductscience.org/library/papers/26865163 | PubMed |
| 15 | 34170969 | Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/34170969 | PubMed |
| 16 | 15858013 | New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. | J Virol | 2005 | https://conductscience.org/library/papers/15858013 | PubMed |
| 17 | 34276680 | AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19. | Front Immunol | 2021 | https://conductscience.org/library/papers/34276680 | PubMed |
| 18 | 30862444 | APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity. | Antiviral Res | 2019 | https://conductscience.org/library/papers/30862444 | PubMed |
| 19 | 23449789 | APOBEC3 inhibition of mouse mammary tumor virus infection: the role of cytidine deamination versus inhibition of reverse transcription. | J Virol | 2013 | https://conductscience.org/library/papers/23449789 | PubMed |
| 20 | 34244677 | Structure and function of retroviral integrase. | Nat Rev Microbiol | 2022 | https://conductscience.org/library/papers/34244677 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42655729 | Molecular Insights into High-Pathogenicity RNA Viruses. | Viruses | 2026 | https://conductscience.org/library/papers/42655729 | PubMed |
| 42267183 | The context-dependent role of the dsRNA response in linking A-to-I editing and ADAR to normal hematopoiesis and leukemia. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42267183 | PubMed |
| 41589909 | MPXV RNA-seq data provide evidence for protection of viral transcripts from APOBEC3 editing. | J Virol | 2026 | https://conductscience.org/library/papers/41589909 | PubMed |
| 41549872 | RNA editing: an emerging frontier in cancer therapy - explorations, opportunities, and challenges. | Int J Surg | 2026 | https://conductscience.org/library/papers/41549872 | PubMed |
| 41393889 | Dancing with the enemy: symbiotic relationships between plant RNA viruses and their hosts. | Front Plant Sci | 2025 | https://conductscience.org/library/papers/41393889 | PubMed |
| 41364244 | RNA editing signatures and codon adaptation reveal potential translational compatibility between Hendra virus and its natural host Pteropus Alecto. | Arch Microbiol | 2025 | https://conductscience.org/library/papers/41364244 | PubMed |
| 41059804 | Role of the epitranscriptome in viral infections: beneficial or detrimental? | Mem Inst Oswaldo Cruz | 2025 | https://conductscience.org/library/papers/41059804 | PubMed |
| 40643565 | Coronaviruses in wild rodent and eulipotyphlan small mammals: a review of diversity, ecological implications and surveillance considerations. | J Gen Virol | 2025 | https://conductscience.org/library/papers/40643565 | PubMed |
| 40622505 | Designing a cellular MicroRNA-based approach to silence bat-borne Nipah virus genes. | J Neurovirol | 2025 | https://conductscience.org/library/papers/40622505 | PubMed |
| 40573348 | Biomedical Interventions for HIV Prevention and Control: Beyond Vaccination. | Viruses | 2025 | https://conductscience.org/library/papers/40573348 | PubMed |
| 39968378 | Editome Disease Knowledgebase v2.0: an updated resource of editome-disease associations through literature curation and integrative analysis. | Bioinform Adv | 2025 | https://conductscience.org/library/papers/39968378 | PubMed |
| 39821161 | BEND6 promotes RNA viruses' replication by inhibiting innate immune responses. | Sci China Life Sci | 2025 | https://conductscience.org/library/papers/39821161 | PubMed |
| 39684407 | The RNA Revolution in the Central Molecular Biology Dogma Evolution. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684407 | PubMed |
| 39415197 | Characterization of the symmetrical benzimidazole twin drug TL1228: the role as viral entry inhibitor for fighting COVID-19. | Biol Direct | 2024 | https://conductscience.org/library/papers/39415197 | PubMed |
| 39408741 | Genomic Landscape and Regulation of RNA Editing in Pekin Ducks Susceptible to Duck Hepatitis A Virus Genotype 3 Infection. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39408741 | PubMed |
| 38848818 | Reovirus infection induces transcriptome-wide unique A-to-I editing changes in the murine fibroblasts. | Virus Res | 2024 | https://conductscience.org/library/papers/38848818 | PubMed |
| 38770134 | RNA editing in host lncRNAs as potential modulator in SARS-CoV-2 variants-host immune response dynamics. | iScience | 2024 | https://conductscience.org/library/papers/38770134 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36978112
GET https://conductscience.org/api/papers/v1/36978112/references?page=2